The overall beneficial effect on glucose control was also seen when looking at the different types of intervention, and the risk of hypoglycemia was similar between the intermediate-acting insulin and basal-bolus insulin interventions (see also Supplementary Appendix, Figs. 3, 4, 5, 6). This evidence concerns the gene INS and Hypoglycemia.